Endocrine-Related Cancer

Top Research Topics at Endocrine-related Cancer?

Endocrine-related Cancer focuses largely on the fields of Internal medicine, Cancer research, Cancer, Endocrinology and Oncology. It dives deep in exploring the relationship between the study of Internal medicine and Gastroenterology. While work presented in the journal provided substantial information on Cancer research, it also covered topics in Cell growth, Cancer cell, Carcinogenesis, Estrogen receptor and Prostate cancer.

It focuses on Prostate cancer but the discussions also offer insight into other areas such as Androgen and Prostate. The presented Cancer research focuses mostly on Pathology and, on occasion, topics in Metastasis. The research on Endocrinology tackled can also make contributions to studies in the areas of Signal transduction and Downregulation and upregulation.

Some problems in Oncology that were presented in the journal overlapped with concepts under Disease and Chemotherapy. Research on Breast cancer presented in it focuses, in particular, on Tamoxifen and Aromatase. It connects the study in Thyroid cancer with the closely related area of Thyroid carcinoma.

• Internal medicine (42.46%)
• Cancer research (37.62%)
• Cancer (20.78%)

What are the most cited papers published in the journal?

• Fibroblast growth factors, their receptors and signaling. (1183 citations)
• BRAF mutation in thyroid cancer (1024 citations)
• Diabetes and cancer (740 citations)

Research areas of the most cited articles at Endocrine-related Cancer:

The most cited papers facilitate discussions on Internal medicine, Cancer research, Endocrinology, Cancer and Oncology. The works on Internal medicine tackled in the most cited articles bring together disciplines like Gastroenterology and Pathology. The most cited publications focus on Endocrinology but the discussions also offer insight into other areas such as Receptor and Cell growth.

What topics the last edition of the journal is best known for?

• Gene
• Cancer
• Internal medicine

The previous edition focused in particular on these issues:

The aim of Endocrine-related Cancer is to expand the discussion of research in Cancer research, Internal medicine, Cancer, Oncology and Thyroid. While Cancer research is the focus of it, it also provided insights into the studies of Epigenetics, Cell cycle, Transcription factor, Gene and Prostate cancer. In addition to Internal medicine research, it aims to explore topics under Gastroenterology and Endocrinology.

Concepts in Cell, as well as related topics in Cell growth, are covered in the Cancer research presented in Endocrine-related Cancer. Topics in Oncology were tackled in line with various other fields like Radiation therapy, Darolutamide, Disease and Stable Disease. The journal tackles studies in Hormone and the interrelated subject of Cancer cell to gain insights into Thyroid.

The most cited articles from the last journal are:

• Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms (8 citations)
• 50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened? (5 citations)
• Role of circadian rhythm disorders in EMT and tumor-immune interactions in endocrine-related cancers. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Endocrine-related Cancer (based on the number of publications) are:

• Constantine A. Stratakis (35 papers) published 1 paper at the last edition, 6 less than at the previous edition,
• Karel Pacak (33 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Ashley B. Grossman (25 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Wouter W. de Herder (24 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Robert Ian Nicholson (22 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Endocrine-related Cancer (based on the number of publications) are:

• National Institutes of Health (104 papers) published 3 papers at the last edition, 12 less than at the previous edition,
• Erasmus University Rotterdam (56 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (50 papers) published 5 papers at the last edition, 5 less than at the previous edition,
• University of Milan (41 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• University of Naples Federico II (38 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.52% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 27.37% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.37% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.00% of all publications and 45.26% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Pathways In The Field of Endocrine-Related Cancer Research

An essential aspect that often gets overlooked in discussions such as these, is understanding the various career pathways and requirements involved within the scope of Endocrine-related Cancer research. Focus on key research areas or the most cited publications is important, but for aspiring professionals or researchers, guidance on carving their careers in this niche is equally vital. Depending on their respective regions, requirements to practice within a research or medical field can drastically vary. For instance, the nebraska nursing license requirements board of nursing requirements has a specific set of expectations for professionals looking to practice in Nebraska, USA. While this article has attempted to underline the diverse aspects of Endocrine-related Cancer research, potential career pathways and the associated necessary qualifications are paramount. Understanding these requirements can provide professionals with a clearer roadmap, letting them streamline their career trajectories effectively. The journey could start from obtaining necessary license, such as the one outlined in Nebraska, and could lead up to highly specialized positions involving endocrine-related cancers and associated research. Knowing this information allows an individual to align their academic and professional pursuits accordingly, ensuring they stay on the right track. This endorses a holistic viewpoint—one that does not just regard the top research topics or most cited papers but also appreciates the underlying professional commitments of those working in this field.